Cefadroxil monohydrate tablet formulation
US6080427A · kind A · utility
4Cited by
15References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 17, 1998 |
| Grant date | Jun 27, 2000 |
| Priority date | — |
| Expiry date | Mar 17, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to uncoated direct compression tablets containing cefadroxil monohydrate as the active ingredient, which are capable of oral administration to human beings by swallowing, chewing or disintegrating in water resulting in a drinkable dispersion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.